Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Avertix Medical

Request full access

A heart-attack warning system that can detect abnormal changes in heart activity and provide an immediate alert if a heart attack is onset

Eatontown, United StatesFounded 2001Biotech & Life Sciences

About Avertix Medical

Avertix operates in the medical device industry, focusing on cardiovascular health. The company's flagship product, the Guardian, is the first and only FDA-approved heart attack warning system. It provides continuous 24/7 monitoring and real-time alerts for abnormal changes in activity, including silent heart attacks. The Guardian system aims to reduce pre-hospital delay, which can significantly improve patient outcomes by ensuring timely medical intervention. The device is available by prescription or physician order in the USA. Avertix primarily serves patients at high risk of recurrent heart attacks, including those with diabetes, kidney disease, or multi-vessel coronary disease. The business model revolves around the sale of the Guardian system and related monitoring services, generating revenue through direct sales to healthcare providers and patients. The company operates in a niche market with a high unmet medical need, offering a unique solution that enhances the diagnosis and management of life-threatening heart conditions.

Source: Dealroom company data

At a glance

Status
Operational
Employees
34
Open positions
None listed
Dealroom signal
61.1/100
Industry
Health
Sub-industry
BioTechnology, Medical Devices, Health Platform
Sector
Biotechnology, Biotech and Pharma, SPAC Target, SPAC IPO Announced, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
B2C

Funding history

9 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
POST IPO DEBTDebt Sep 2024 $15M — Undisclosed ↗
SPAC IPOOther financing May 2023 $200M $200M BIOS Acquisition Corporation (dba BioPlus Acquisition Corp) ↗
Showing the latest 2 of 9 recorded eventsBook a demo for the full funding history →

Growth signals

Avertix Medical website traffic

Latest recorded traffic for Avertix Medical is 3.5K monthly website visits, up 84.2% over the last three months. Avertix Medical's team declined 26.1% over the past year.

Latest monthly visits3.5K 3-month web change+84.2% 1-year team growth-26.1%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Avertix Medical in the Eatontown ecosystem

Live from Dealroom

The Avertix Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later1 investor entered at this stage

  • BIOS Acquisition Corporation (dba BioPlus Acquisition Corp)
Team profiled 13 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Avertix Medical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Avertix Medical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.